These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6117519)

  • 1. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-blocking effect of diacetolol in humans and its relationship to plasma levels.
    Flouvat B; Roux A; Delhotal B; Lemaigre D; Leroy M; Liot F
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):358-61. PubMed ID: 6126441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocking potency and electrophysiologic effects of acebutolol.
    Singh BN; Williams R; Harrison DC
    Am Heart J; 1985 May; 109(5 Pt 2):1126-31. PubMed ID: 2859775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL; Levin DC; Manion CV
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of propranolol and acebutolol on isoprenaline-induced changes in heart rate and peripheral blood flow in man.
    Mougeot G; Hugues FC; Julien D; Marche J
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):116-25. PubMed ID: 7259364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of equipotent blocking doses of acebutolol, acebutolol's primary metabolite, and propranolol on left ventricular hemodynamics in conscious awake dogs.
    Magder S; Rubenson D; Griffin G; Kernoff R; Harrison DC
    J Cardiovasc Pharmacol; 1983; 5(4):691-6. PubMed ID: 6193369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of acebutolol].
    Collins RF
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3223-8. PubMed ID: 768905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced exercise noradrenaline concentrations during propranolol treatment: a limiting factor in cardiac beta-adrenoceptor blockade.
    Hurwitz GA; Webb JG; Walle T; Gourley LA; Cobb L
    Can J Cardiol; 1988 Sep; 4(6):262-9. PubMed ID: 2846132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
    Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
    Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and pulmonary effects of acebutolol.
    Kumana CR; Kaye CM; Leighton M; Turner P; Hamer J
    Lancet; 1975 Jul; 2(7925):89-93. PubMed ID: 49736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between clinical and exercise responsiveness to beta-blockade in angina.
    Tremblay G; Biron P; Proulx A
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):508-12. PubMed ID: 32144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose-response relationship and duration of action of acebutolol / investigations on heart rate behaviour and ischemic ST-segment depression].
    Kober G; Mikludy R; Veidt J; Kaltenbach M
    Arzneimittelforschung; 1982; 32(8):835-9. PubMed ID: 6890361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.